Literature DB >> 18987161

Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.

Daquan Gao1, Diwahar L Narasimhan, Joanne Macdonald, Remy Brim, Mei-Chuan Ko, Donald W Landry, James H Woods, Roger K Sunahara, Chang-Guo Zhan.   

Abstract

Enhancing cocaine metabolism by administration of cocaine esterase (CocE) has been recognized as a promising treatment strategy for cocaine overdose and addiction, because CocE is the most efficient native enzyme for metabolizing the naturally occurring cocaine yet identified. A major obstacle to the clinical application of CocE is the thermoinstability of native CocE with a half-life of only a few minutes at physiological temperature (37 degrees C). Here we report thermostable variants of CocE developed through rational design using a novel computational approach followed by in vitro and in vivo studies. This integrated computational-experimental effort has yielded a CocE variant with a approximately 30-fold increase in plasma half-life both in vitro and in vivo. The novel design strategy can be used to develop thermostable mutants of any protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987161      PMCID: PMC2684895          DOI: 10.1124/mol.108.049486

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  Native protein sequences are close to optimal for their structures.

Authors:  B Kuhlman; D Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Computational design of a biologically active enzyme.

Authors:  Mary A Dwyer; Loren L Looger; Homme W Hellinga
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

3.  Addiction as a computational process gone awry.

Authors:  A David Redish
Journal:  Science       Date:  2004-12-10       Impact factor: 47.728

4.  Modulating calmodulin binding specificity through computational protein design.

Authors:  Julia M Shifman; Stephen L Mayo
Journal:  J Mol Biol       Date:  2002-10-25       Impact factor: 5.469

5.  Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase.

Authors:  Ziva D Cooper; Diwahar Narasimhan; Roger K Sunahara; Pawel Mierzejewski; Emily M Jutkiewicz; Nicholas A Larsen; Ian A Wilson; Donald W Landry; James H Woods
Journal:  Mol Pharmacol       Date:  2006-09-12       Impact factor: 4.436

Review 6.  Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.

Authors:  D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

7.  Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1.

Authors:  M M Bresler; S J Rosser; A Basran; N C Bruce
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

8.  Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening.

Authors:  Peizhi Luo; Robert J Hayes; Cheryl Chan; Diane M Stark; Marian Y Hwang; Jonathan M Jacinto; Padmaja Juvvadi; Helen S Chung; Anirban Kundu; Marie L Ary; Bassil I Dahiyat
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

9.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

10.  A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats.

Authors:  B Mets; G Winger; C Cabrera; S Seo; S Jamdar; G Yang; K Zhao; R J Briscoe; R Almonte; J H Woods; D W Landry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more
  47 in total

1.  Uricases as therapeutic agents to treat refractory gout: Current states and future directions.

Authors:  Xiaolan Yang; Yonghua Yuan; Chang-Guo Zhan; Fei Liao
Journal:  Drug Dev Res       Date:  2011-12-29       Impact factor: 4.360

2.  Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Authors:  Tien-Yi Lee; Yoon Shin Park; George A Garcia; Roger K Sunahara; James H Woods; Victor C Yang
Journal:  Mol Pharm       Date:  2012-03-28       Impact factor: 4.939

3.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

4.  Novel pharmacological approaches to treatment of drug overdose and addiction.

Authors:  Chang-Guo Zhan
Journal:  Expert Rev Clin Pharmacol       Date:  2009       Impact factor: 5.045

Review 5.  Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Authors:  Diwahar Narasimhan; James H Woods; Roger K Sunahara
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 6.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

7.  Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

8.  Rapid Bioinformatic Identification of Thermostabilizing Mutations.

Authors:  David B Sauer; Nathan K Karpowich; Jin Mei Song; Da-Neng Wang
Journal:  Biophys J       Date:  2015-10-06       Impact factor: 4.033

9.  Enzyme-therapy approaches for the treatment of drug overdose and addiction.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

10.  Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.

Authors:  Lei Fang; Shurong Hou; Liu Xue; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2014-02-25       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.